Matches in Nanopublications for { ?s ?p "[RAIA metastatic FCDTC are overrepresented with RAS mutations, whereas RAI refractory metastatic thyroid cancers are enriched with BRAF mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP275532.RA26vut3y3K_IliVLAb_162124LW4i_0jOuPxC5CBGARU130_assertion description "[RAIA metastatic FCDTC are overrepresented with RAS mutations, whereas RAI refractory metastatic thyroid cancers are enriched with BRAF mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP275532.RA26vut3y3K_IliVLAb_162124LW4i_0jOuPxC5CBGARU130_provenance.
- assertion description "[RAIA metastatic FCDTC are overrepresented with RAS mutations, whereas RAI refractory metastatic thyroid cancers are enriched with BRAF mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[RAIA metastatic FCDTC are overrepresented with RAS mutations, whereas RAI refractory metastatic thyroid cancers are enriched with BRAF mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP367931.RAGTMudKRmY_geTq1zdPRdRoR2Dn6Y7gEkrYCEkpninRc130_assertion description "[RAIA metastatic FCDTC are overrepresented with RAS mutations, whereas RAI refractory metastatic thyroid cancers are enriched with BRAF mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367931.RAGTMudKRmY_geTq1zdPRdRoR2Dn6Y7gEkrYCEkpninRc130_provenance.
- NP534443.RAPqjjERWop3nS410hmWejXMsiak8zDZ5vnsq4Q6-NNd8130_assertion description "[RAIA metastatic FCDTC are overrepresented with RAS mutations, whereas RAI refractory metastatic thyroid cancers are enriched with BRAF mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP534443.RAPqjjERWop3nS410hmWejXMsiak8zDZ5vnsq4Q6-NNd8130_provenance.
- NP1063971.RAMPb1MrykU9nyu833qMGVvN-iEuBn2BP2JUwEtjA-x3w130_assertion description "[RAIA metastatic FCDTC are overrepresented with RAS mutations, whereas RAI refractory metastatic thyroid cancers are enriched with BRAF mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1063971.RAMPb1MrykU9nyu833qMGVvN-iEuBn2BP2JUwEtjA-x3w130_provenance.
- NP1063972.RAEIPgTgRsA_M-qqPALjYHgllwNcLRPIGuN34YSYCiFEk130_assertion description "[RAIA metastatic FCDTC are overrepresented with RAS mutations, whereas RAI refractory metastatic thyroid cancers are enriched with BRAF mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1063972.RAEIPgTgRsA_M-qqPALjYHgllwNcLRPIGuN34YSYCiFEk130_provenance.